Table 2.
Group | N | Protein expression of FAK | Protein expression of p-PI3K | Protein expression of Aggrecan |
---|---|---|---|---|
Control | 6 | 0.06 ± 0.01 | 0.14 ± 0.02 | 1.54 ± 0.16 |
Model | 6 | 0.45 ± 0.13∗∗ | 0.41 ± 0.18∗∗ | 0.59 ± 0.11∗∗ |
Model-inhibitor | 6 | 0.15 ± 0.15Δ | 0.22 ± 0.09Δ | 0.19 ± 0.05ΔΔ |
Needle knife | 6 | 2.32 ± 0.32∗∗##▲▲ | 0.83 ± 0.19∗∗##▲▲ | 1.11 ± 0.16∗∗##▲▲ |
Needle knife-inhibitor | 6 | 1.95 ± 0.35Δ | 0.65 ± 0.18Δ | 0.69 ± 0.08ΔΔ |
Electroacupuncture | 6 | 1.25 ± 0.28∗∗## | 0.60 ± 0.17∗∗# | 0.76 ± 0.14∗∗# |
Electroacupuncture inhibitor | 6 | 0.92 ± 0.23Δ | 0.41 ± 0.15Δ | 0.37 ± 0.13ΔΔ |
Versus normal group: P∗∗ < 0.01; versus model group: P# < 0.05 and P## < 0.01; versus electroacupuncture group: P▲▲ < 0.01; versus noninhibitor group: PΔ < 0.05 and PΔΔ < 0.01.